Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study

Overview of attention for article published in Cancer Management and Research, August 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 15,738 followers.

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and de... https://t.co/8PU9nz9d7l

Reply Repost Favourite

Single Chinese center retrospective study finds 68.5% response rate for #Velcade/dex as induction for #myeloma: https://t.co/WLMpA3RGnd. https://t.co/2wtQf2Jxmf

Reply Repost Favourite

PC | #CancerManagRes Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients… https://t.co/POdx7sLocV

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.